Abstract
Serum specimens from 25 individuals with an isolated human immunodeficiency virus type 1 (HIV-1) core antigen reactivity in a Western immunoblot test were examined for their reactivities with HIV-1 virions, control cellular antigens, HIV-1-Bru p24gag recombinant protein (p24gag), and a panel of 22 p24gag-derived peptides. The results were as follows: (i) serum specimens from eight HIV-1-uninfected subjects did bind to virions but failed to bind to p24gag; (ii) sera from 13 HIV-1-uninfected subjects and from one HIV-2-infected patient reacted with HIV-1 virions and p24gag but failed to bind to any of the peptides expressing major p24gag epitopes, and (iii) 3 serum specimens obtained from one neonate carrying anti-HIV-1 maternal antibody and from two HIV-1-infected subjects who had seroconverted during the study reacted with HIV-1 virions, p24gag, and one or more peptides containing the major p24gag epitopes. Our data suggest that the combination of p24gag and appropriate peptides could be useful for resolution when atypical Western immunoblot results are encountered.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Adachi M., Hayami M., Kashiwagi N., Mizuta T., Ohta Y., Gill M. J., Matheson D. S., Tamaoki T., Shiozawa C., Hakomori S. Expression of Ley antigen in human immunodeficiency virus-infected human T cell lines and in peripheral lymphocytes of patients with acquired immune deficiency syndrome (AIDS) and AIDS-related complex (ARC). J Exp Med. 1988 Feb 1;167(2):323–331. doi: 10.1084/jem.167.2.323. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Barré-Sinoussi F., Chermann J. C., Rey F., Nugeyre M. T., Chamaret S., Gruest J., Dauguet C., Axler-Blin C., Vézinet-Brun F., Rouzioux C. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science. 1983 May 20;220(4599):868–871. doi: 10.1126/science.6189183. [DOI] [PubMed] [Google Scholar]
- Bürgisser P., Frei P. C. Characterization of antibodies reacting with HIV gag proteins occasionally found in the serum of non-infected subjects. Clin Exp Immunol. 1991 Aug;85(2):219–223. doi: 10.1111/j.1365-2249.1991.tb05708.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Corbeau P., Devaux C., Kourilsky F., Chermann J. C. An early postinfection signal mediated by monoclonal anti-beta 2 microglobulin antibody is responsible for delayed production of human immunodeficiency virus type 1 in peripheral blood mononuclear cells. J Virol. 1990 Apr;64(4):1459–1464. doi: 10.1128/jvi.64.4.1459-1464.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
- De Cock K. M., Porter A., Kouadio J., Maran M., Lafontaine M. F., Gershy-Damet G. M., Heyward W. L., George R. Cross-reactivity on western blots in HIV-1 and HIV-2 infections. AIDS. 1991 Jul;5(7):859–863. doi: 10.1097/00002030-199107000-00010. [DOI] [PubMed] [Google Scholar]
- Gaines H., von Sydow M., Sönnerborg A., Albert J., Czajkowski J., Pehrson P. O., Chiodi F., Moberg L., Fenyö E. M., Asjö B. Antibody response in primary human immunodeficiency virus infection. Lancet. 1987 May 30;1(8544):1249–1253. doi: 10.1016/s0140-6736(87)92696-1. [DOI] [PubMed] [Google Scholar]
- Hinkula J., Rosen J., Sundqvist V. A., Stigbrand T., Wahren B. Epitope mapping of the HIV-1 gag region with monoclonal antibodies. Mol Immunol. 1990 May;27(5):395–403. doi: 10.1016/0161-5890(90)90163-t. [DOI] [PubMed] [Google Scholar]
- Huet T., Dazza M. C., Brun-Vézinet F., Roelants G. E., Wain-Hobson S. A highly defective HIV-1 strain isolated from a healthy Gabonese individual presenting an atypical western blot. AIDS. 1989 Nov;3(11):707–715. doi: 10.1097/00002030-198911000-00004. [DOI] [PubMed] [Google Scholar]
- Jackson J. B., MacDonald K. L., Cadwell J., Sullivan C., Kline W. E., Hanson M., Sannerud K. J., Stramer S. L., Fildes N. J., Kwok S. Y. Absence of HIV infection in blood donors with indeterminate western blot tests for antibody to HIV-1. N Engl J Med. 1990 Jan 25;322(4):217–222. doi: 10.1056/NEJM199001253220402. [DOI] [PubMed] [Google Scholar]
- Janvier B., Archinard P., Mandrand B., Goudeau A., Barin F. Linear B-cell epitopes of the major core protein of human immunodeficiency virus types 1 and 2. J Virol. 1990 Sep;64(9):4258–4263. doi: 10.1128/jvi.64.9.4258-4263.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Janvier B., Baillou A., Archinard P., Mounier M., Mandrand B., Goudeau A., Barin F. Immune response to a major epitope of p24 during infection with human immunodeficiency virus type 1 and implications for diagnosis and prognosis. J Clin Microbiol. 1991 Mar;29(3):488–492. doi: 10.1128/jcm.29.3.488-492.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Josephson S. L., Swack N. S., Ramirez M. T., Hausler W. J., Jr Investigation of atypical western blot (immunoblot) reactivity involving core proteins of human immunodeficiency virus type. J Clin Microbiol. 1989 May;27(5):932–937. doi: 10.1128/jcm.27.5.932-937.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kleinman S., Fitzpatrick L., Secord K., Wilke D. Follow-up testing and notification of anti-HIV Western blot atypical (indeterminant) donors. Transfusion. 1988 May-Jun;28(3):280–282. doi: 10.1046/j.1537-2995.1988.28388219161.x. [DOI] [PubMed] [Google Scholar]
- Langedijk J. P., Schalken J. J., Tersmette M., Huisman J. G., Meloen R. H. Location of epitopes on the major core protein p24 of human immunodeficiency virus. J Gen Virol. 1990 Nov;71(Pt 11):2609–2614. doi: 10.1099/0022-1317-71-11-2609. [DOI] [PubMed] [Google Scholar]
- Medstrand P., Lindeskog M., Blomberg J. Expression of human endogenous retroviral sequences in peripheral blood mononuclear cells of healthy individuals. J Gen Virol. 1992 Sep;73(Pt 9):2463–2466. doi: 10.1099/0022-1317-73-9-2463. [DOI] [PubMed] [Google Scholar]
- Povolotsky J., Gold J. W., Chein N., Baron P., Armstrong D. Differences in human immunodeficiency virus type 1 (HIV-1) anti-p24 reactivities in serum of HIV-1-infected and uninfected subjects: analysis of indeterminate western blot reactions. J Infect Dis. 1991 Feb;163(2):247–251. doi: 10.1093/infdis/163.2.247. [DOI] [PubMed] [Google Scholar]
- Rhame F. S., Maki D. G. The case for wider use of testing for HIV infection. N Engl J Med. 1989 May 11;320(19):1248–1254. doi: 10.1056/NEJM198905113201905. [DOI] [PubMed] [Google Scholar]
- Robert-Hebmann V., Emiliani S., Jean F., Resnicoff M., Traincard F., Devaux C. Clonal analysis of murine B cell response to the human immunodeficiency virus type 1 (HIV1)-gag p17 and p25 antigens. Mol Immunol. 1992 Jun;29(6):729–738. doi: 10.1016/0161-5890(92)90183-x. [DOI] [PubMed] [Google Scholar]
- Robert-Hebmann V., Emiliani S., Resnicoff M., Jean F., Devaux C. Subtyping of human immunodeficiency virus isolates with a panel of monoclonal antibodies: identification of conserved and divergent epitopes on p17 and p25 core proteins. Mol Immunol. 1992 Oct;29(10):1175–1183. doi: 10.1016/0161-5890(92)90053-z. [DOI] [PubMed] [Google Scholar]
- Robert V., Resnicoff M., Chermann J. C., Devaux C. Characterization of monoclonal antibodies identifying type and strain-specific epitopes of human immunodeficiency virus type 1. Mol Cell Biochem. 1991 Apr 10;102(2):115–123. doi: 10.1007/BF00234569. [DOI] [PubMed] [Google Scholar]
- van der Poel C. L., Reesink H. W., Tersmette T., Lelie P. N., Huisman H., Miedema F. Blood donations reactive for HIV in Western blot, but non-infective in culture and recipients of blood. Lancet. 1986 Sep 27;2(8509):752–753. doi: 10.1016/s0140-6736(86)90273-4. [DOI] [PubMed] [Google Scholar]